Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700622 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks
A Phase 3 study, sponsored by Mannkind Corporation.
- Terminated
- Registry status
- Phase 3
- Development phase
- 130
- Enrollment target
NCT00700622: Clinical Trial Phase 3 study, sponsored by Mannkind Corporation.
NCT00700622 is a Phase 3 study that was terminated before completion, run by Mannkind Corporation. The registered enrollment target is 130 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00700622, a Phase 3 study, was terminated before completion, sponsored by Mannkind Corporation.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 130 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate that TI® Inhalation Powder combined with Lantus® is as effective as Humalog® combined with Lantus® on HbA1c.
Primary Outcome
Change from Baseline in glycosylated hemoglobin at Week 16
Interventions
- DRUG Technosphere Insulin
- DRUG Insulin glargine
- DRUG Insulin lispro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-03 |
| Phase | Phase 3 |
Why NCT00700622 stopped before completion
NCT00700622 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 3 interventions - of which Technosphere Insulin is the first listed.
NCT00700622 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00700622 about?
NCT00700622 is a clinical study titled "Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks". The objective of this study is to demonstrate that TI® Inhalation Powder combined with Lantus® is as effective as Humalog® combined with Lantus® on HbA1c.
What is the current status of trial NCT00700622?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 130 participants. The study started on 2008-05. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00700622?
The interventions under investigation include: Technosphere Insulin (DRUG), Insulin glargine (DRUG), Insulin lispro (DRUG).
Who is sponsoring clinical trial NCT00700622?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00700622's enrollment target sits among peer trials
130 1594th of 2000 higher than 404 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia